📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Protection against RNA-induced liver damage by myeloid cells requires type I interferon and IL-1 receptor antagonist in mice. (2014)

First Author: Conrad E

Attributed to: MRC Centre for Transplantation funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1002/hep.26915

PubMed Identifier: 24677196

Publication URI: http://europepmc.org/abstract/MED/24677196

Type: Journal Article/Review

Volume: 59

Parent Publication: Hepatology (Baltimore, Md.)

Issue: 4

ISSN: 0270-9139